Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment

Overview of attention for article published in Journal of Nanobiotechnology, October 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 9,794 followers.

RT @ExtracellMatrix: In this @JNanobiotech paper, researchers exploit atovaquone and albumin #nanoparticles to improve #bioavailability and…

RT @ExtracellMatrix: In this @JNanobiotech paper, researchers exploit atovaquone and albumin #nanoparticles to improve #bioavailability and…

In this @JNanobiotech paper, researchers exploit atovaquone and albumin #nanoparticles to improve #bioavailability and tumor targeting of atovaquone, enhancing the efficacy of anti-PD-1 therapy by normalizing tumor hypoxia. 🔬 https://t.co/5TmO3feYf7 https

Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment https://t.co/fPONcJf7tm

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.